etoposide has been researched along with natriuretic peptide, brain in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 2 (40.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayama, M; Higashihara, M; Kajiwara, K; Khori, M; Niitsu, N; Tamaru, J | 1 |
| Ala-Kopsala, M; Hartikainen, J; Jantunen, E; Kuittinen, T; Mussalo, H; Nousiainen, T; Vanninen, E; Vuolteenaho, O | 1 |
| Altena, R; Brouwer, CA; de Haas, EC; Gietema, JA; Nuver, J; Postma, A; Sleijfer, DT; Smit, AJ; van den Berg, MP | 1 |
| Altena, R; Boezen, HM; de Boer, RA; de Vries, EG; Gietema, JA; Hummel, YM; Lefrandt, JD; Nuver, J; Smit, AJ; van den Berg, MP; Voors, AA | 1 |
| Bal, C; Gulbas, Z; Ozkan, HA | 1 |
1 trial(s) available for etoposide and natriuretic peptide, brain
| Article | Year |
|---|---|
Phase I/II study of the rituximab-EPOCT regimen in combination with granulocyte colony-stimulating factor in patients with relapsed or refractory follicular lymphoma including evaluation of its cardiotoxicity using B-type natriuretic peptide and troponin
Topics: Adult; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Etoposide; Female; Granulocyte Colony-Stimulating Factor; Heart Diseases; Humans; Lymphoma, Follicular; Male; Middle Aged; Natriuretic Peptide, Brain; Neoplasm Recurrence, Local; Prednisone; Receptors, IgG; Remission Induction; Rituximab; Salvage Therapy; Troponin T; Vincristine | 2005 |
4 other study(ies) available for etoposide and natriuretic peptide, brain
| Article | Year |
|---|---|
Cardiac effects within 3 months of BEAC high-dose therapy in non-Hodgkin's lymphoma patients undergoing autologous stem cell transplantation.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Atrial Natriuretic Factor; Biomarkers; Carmustine; Cyclophosphamide; Cytarabine; Etoposide; Female; Gated Blood-Pool Imaging; Heart; Humans; Lymphoma, Non-Hodgkin; Male; Middle Aged; Natriuretic Peptide, Brain; Peptide Fragments; Peripheral Blood Stem Cell Transplantation; Postoperative Complications; Postoperative Period; Prospective Studies; Protein Precursors; Sensitivity and Specificity; Stroke Volume; Systole; Transplantation, Autologous; Ventricular Dysfunction, Left | 2006 |
Evaluation of sub-acute changes in cardiac function after cisplatin-based combination chemotherapy for testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Cohort Studies; Echocardiography; Etoposide; Heart; Humans; Male; Middle Aged; Natriuretic Peptide, Brain; Orchiectomy; Peptide Fragments; Prognosis; Prospective Studies; Risk Factors; Testicular Neoplasms; Ventricular Dysfunction, Left; Young Adult | 2009 |
Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Disease Progression; Echocardiography; Etoposide; Galectin 3; Heart Diseases; Humans; Longitudinal Studies; Male; Middle Aged; Natriuretic Peptide, Brain; Testicular Neoplasms; Ventricular Dysfunction, Left; Young Adult | 2011 |
Assessment and comparison of acute cardiac toxicity during high-dose cyclophosphamide and high-dose etoposide stem cell mobilization regimens with N-terminal pro-B-type natriuretic peptide.
Topics: Adult; Aged; Antineoplastic Agents; Cardiotoxicity; Cyclophosphamide; Etoposide; Female; Heart; Hematologic Neoplasms; Hematopoietic Stem Cell Mobilization; Humans; Male; Middle Aged; Myocardium; Natriuretic Peptide, Brain; Peptide Fragments; Prospective Studies; Risk; ROC Curve; Time Factors; Treatment Outcome; Young Adult | 2014 |